Glenmark Pharmaceuticals Ltd Sustainability Reports

A research-driven, global, integrated pharmaceutical company focusing on generics, specialty, and OTC products, with key expertise in dermatology, respiratory, and oncology therapies.

Sector: Manufacturing

Country: India

Exchange: National Stock Exchange of India

ISIN: INE935A01035

27 reports from 2011 to 2025

• Glenmark Pharmaceuticals Ltd 2025 Annual Secretarial Compliance Report
• Glenmark Pharmaceuticals Ltd 2025 Integrated Annual Report
• Glenmark Pharmaceuticals Ltd 2025 ESG Factbook
• Glenmark Pharmaceuticals Ltd 2024 Integrated Annual Report
• Glenmark Pharmaceuticals Ltd 2024 CSR Impact Assessment Summary Report